510(k) K781381
K781381 is an FDA 510(k) premarket notification submitted by Dade Behring, Inc. for the device "EMIT METHATREXATE ASSAY". The FDA issued a decision of Substantially Equivalent on October 10, 1978. The device falls under product code LAO (Enzyme Immunoassay, Methotrexate), a Class U device. Dade Behring, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 10, 1978
- Date Received
- August 11, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Methotrexate
- Device Class
- Class U
- Regulation Number
- Review Panel
- TX
- Submission Type